Nutrient Metabolism Unique Uptake and Transport of Isoflavone Aglycones by Human Intestinal Caco-2 Cells : Comparison of Isoflavonoids and Flavonoids 1

Soy isoflavonoids have attracted much attention because of their estrogenic activity. To study the intestinal absorption of the isoflavonoids, we investigated the cellular uptake and metabolism of genistein and daidzein and their glucosides, genistin and daidzin, by Caco-2 cell monolayers as a model of the human intestinal epithelium. When Caco-2 monolayers were incubated with genistein or daidzein at 10 mol/L from the apical (mucosal) side, aglycone was lost from the apical solution for 2.0 h (P 0.05) and the glucuronide/sulfates appeared at the level of 1–2 mol/L. In the basolateral (serosal) solution, both intact aglycones and their glucuronide/sulfates increased (P 0.05) with time and reached 20 and 15% of the initial dose, respectively. The transport of their glucosides, genistin and daidzin, through Caco-2 monolayers was less than one tenth that of the aglycones. The cellular metabolism of genistein was compared with quercetin, kaempferol, luteolin and apigenin. Only genistein aglycone was transported intact to the basolateral solution. Transport was greater (P 0.05) than that of flavonoid aglycones and was without an appreciable decrease of transepithelial resistance. Radical scavenging activity was not related to the susceptibility to conjugation of flavonoids/isoflavonoids. Affinity to the liposomal membrane was increased in the order of genistin daidzin daidzein genistein flavonoid aglycones. These results strongly suggest that isoflavone aglycones are taken up into enterocytes more efficiently than their glucosides because of their moderate lipophilicity. Furthermore, they are generally transported to the basolateral side in intact form in contrast to flavonoids, probably due to their unique isoflavonoid structure. J. Nutr. 132: 1956–1961, 2002.

[1]  M. Kushiro,et al.  Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells. , 2001, The Journal of nutrition.

[2]  J. Terao,et al.  Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-D-glucuronide, on lipid peroxidation in liposomal membranes. , 2001, Journal of agricultural and food chemistry.

[3]  S. Nigam,et al.  Reassembly of the Tight Junction after Oxidative Stress Depends on Tyrosine Kinase Activity* , 2001, The Journal of Biological Chemistry.

[4]  J. Terao,et al.  Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. , 2001, Free radical biology & medicine.

[5]  M. Herderich,et al.  Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[6]  K. Setchell,et al.  Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. , 2001, The Journal of nutrition.

[7]  J. Terao,et al.  Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. , 2000, Archives of biochemistry and biophysics.

[8]  T. Inakuma,et al.  Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  M. Kikuchi,et al.  Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. , 2000, The Journal of nutrition.

[10]  P. Fürst,et al.  Absorption and metabolism of genistin in the isolated rat small intestine , 2000, FEBS letters.

[11]  J. Cooke,et al.  Phytoestrogens and cardiovascular health. , 2000, Journal of the American College of Cardiology.

[12]  M. Reddy,et al.  Caco-2 cells can be used to assess human iron bioavailability from a semipurified meal. , 2000, The Journal of nutrition.

[13]  P. Stehle,et al.  Absorption and metabolism of genistein in isolated rat small intestine. , 2000, The Journal of nutrition.

[14]  G. Williamson,et al.  Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase , 2000, FEBS letters.

[15]  C. Manach,et al.  Quercetin 3-O-β-glucoside is better absorbed than other quercetin forms and is not present in rat plasma , 2000, Free radical research.

[16]  M. Churchwell,et al.  Quantification of soy isoflavones, genistein and daidzein, and conjugates in rat blood using LC/ES-MS. , 1999, Journal of agricultural and food chemistry.

[17]  G Williamson,et al.  Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β‐glucosidase activity , 1998, FEBS letters.

[18]  J. Terao,et al.  beta-Glucosidase activity in the rat small intestine toward quercetin monoglucosides. , 1998, Bioscience, biotechnology, and biochemistry.

[19]  J. Terao,et al.  Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. , 1998, The Journal of nutrition.

[20]  E. Levy,et al.  Caco‐2 cells as a model for intestinal lipoprotein synthesis and secretion , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  B. Goldin,et al.  Soybean phytoestrogen intake and cancer risk. , 1995, The Journal of nutrition.

[22]  P. Murphy,et al.  Isoflavone content in commercial soybean foods , 1994 .

[23]  H. Adlercreutz,et al.  Plasma concentrations of phyto-oestrogens in Japanese men , 1993, The Lancet.

[24]  T. Hase,et al.  Expedient Synthesis of Polyhydroxyisoflavones. , 1992 .

[25]  Thomas J. Raub,et al.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.

[26]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[27]  G. Chang,et al.  A COLON-SPECIFIC DRUG-DELIVERY SYSTEM BASED ON DRUG GLYCOSIDES AND THE GLYCOSIDASES OF COLONIC BACTERIA , 1984 .

[28]  J. Fogh,et al.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors. , 1977, Journal of the National Cancer Institute.

[29]  M. S. Blois,et al.  Antioxidant Determinations by the Use of a Stable Free Radical , 1958, Nature.

[30]  R. Walgren,et al.  Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2. , 1999, Research communications in molecular pathology and pharmacology.

[31]  S. C. Garner,et al.  Phytoestrogens and bone. , 1998, Bailliere's clinical endocrinology and metabolism.

[32]  R. Prior,et al.  Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. , 1997, Free radical biology & medicine.

[33]  S. Barnes,et al.  Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. , 1996, Advances in experimental medicine and biology.

[34]  S. Barnes,et al.  Soy intake and cancer risk: a review of the in vitro and in vivo data. , 1994, Nutrition and cancer.